Search Results < Directory of Faculty Research Interests

85 results

News
Yale New Haven Health and Yale University celebrate Innovation Awards
Yale New Haven Health (YNHHS) celebrated the second YNHHS Innovation Awards Ceremony, where five outstanding teams were each awarded $100,000 to bring their groundbreaking projects to life.
Source: Yale New Haven Health
12 Jun 2024
News
Profiles in Survivorship: Craig Studer
Profiles in Survivorship: Craig Studer
8 Jun 2024
News
Yale Cancer Center Researchers and Trainees Present at ASCO
Yale Cancer Center scientists and trainees attended the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago May 31-June 4 to present research advances from Yale Cancer Center and Smilow Cancer Hospital. The ASCO meeting is the most significant gathering of oncology professionals worldwide, initiating connections and forging collaborations that can change the landscape of cancer care.
7 Jun 2024
News
Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses
Speaking about computer modeling to pinpoint the optimal dose — despite its lack of precision, this approach is by far the most widely used in cancer clinical trials of experimental drugs, said workshop co-chair Patricia M. LoRusso, DO, of Yale Cancer Center.
Source: National Cancer Institute
6 Jun 2024
News
Promising New Treatment for Some Patients with Metastatic Breast Cancer
New research from Yale Cancer Center (YCC) reveals first-of-its-kind data from a phase I study in patients with hormone receptor positive HER2-negative metastatic breast cancer. Senior author Patricia LoRusso, DO, YCC's Associate Director for Experimental Therapeutics will present the findings at the American Society of Clinical Oncology Annual Meeting on June 1.
30 May 2024
News
New Research and Treatment Advances From Yale Cancer Center to be Presented at the World’s Largest Cancer Research Conference
The 48 Yale Cancer Center presentations will include phase II trial results for a cancer vaccine in combination with an immunotherapy drug, a new tool to predict the risk of recurrence of hormone receptor-positive, HER2-negative breast cancer, and the factors affecting sexual function of young women with breast cancer.
13 May 2024
News
Dr. Patricia LoRusso: Focus on Research, Clinical Trials
A conversation with Patricia LoRusso, DO, PhD (h) who became president of American Association of Cancer Research in April 2024 at the annual meeting in San Diego.
3 May 2024
News
Why Clinical Trials Are Critical
An interview with Dr. Patricia LoRusso, Yale School of Medicine professor of Medicine (Medical Oncology), chief of the Early Therapeutics Program, and Associate Yale Cancer Center Director for Experimental Therapeutics. In April 2024 she became president of the American Association for Cancer Research (AACR)
15 Apr 2024
News
The Cancer Moonshot: Opportunities to Fulfill the Vision of the National Cancer Plan
The Reignited Cancer Moonshot launched by President Biden seeks to mobilize resources and forge partnerships in the fight against cancer with the goals of reducing cancer death rates by half within 25 years and improving the lives of both people with cancer and cancer survivors. As part of the Moonshot, the National Cancer Institute (NCI) has outlined a bold roadmap, the National Cancer Plan, to advance research and intervention strategies to improve cancer prevention, detection, and treatment, and to reduce cancer inequities. However, the historic bipartisan support in Congress for federal biomedical research funding has eroded. As a result, biomedical researchers are currently facing a crisis. The National Institutes of Health (NIH) budget is stagnant for the first time in eight years, jeopardizing further progress against cancer and a multitude of other diseases and health challenges.
12 Apr 2024
News
Yale Cancer Center Faculty and Trainees Present at AACR Annual Meeting
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
12 Apr 2024
News
Patricia M. LoRusso, DO, PhD, (HC), FAACR, Begins Term as AACR President
The members of the American Association for Cancer Research (AACR) have welcomed Patricia M. LoRusso, DO, PhD (hc), Fellow of the AACR Academy, as the AACR President for 2024-2025. She was inaugurated today at the AACR’s Annual Business Meeting of Members, held during the AACR Annual Meeting 2024 in San Diego, California. LoRusso is a professor of medicine (medical oncology), chief of experimental therapeutics, associate cancer center director for experimental therapeutics, and leader of the Phase I disease aligned research team at Yale Cancer Center and Smilow Cancer Hospital. An internationally recognized expert in drug development and early-phase clinical investigation of novel therapies, LoRusso’s innovative and tireless leadership has helped shape the field of translational and clinical cancer research and has greatly contributed to crucial therapeutic breakthroughs for patients with cancer.
Source: AACR
8 Apr 2024
News
Yale Cancer Center Experts, Scientists to Share Vision and Research at Leading Conference
Yale Cancer Center researchers will present their new cancer research findings at the 2024 AACR annual meeting. A few of the presenting YCC researchers offer their key study takeaways and the significance for patients and oncologists.
1 Apr 2024
News
Breast cancer research
Declines in the death rate for breast cancer have furthered overall progress in cancer mortality.
20 Mar 2024
News
Yale Cancer Center Experts Present New Research on Obesity, Tobacco, Evolution, and Early Onset Cancers at Leading Oncology Conference
Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
18 Mar 2024
News
As cancer treatment advances, patients and doctors push back against drugs’ harsh side effects
“We were pushing the dose as high as we could go,” said Dr. Patricia LoRusso, who leads drug discovery and development at Yale Cancer Center. “You get side effects and then you have to stop the drug to recover from the side effects and the tumor can grow.”
Source: Associated Press
6 Feb 2024
News
As cancer treatment advances, patients and doctors push back against drugs' harsh side effects
Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable.
Source: ABC News
6 Feb 2024
News
LoRusso Named the Amy and Joseph Perella Professor of Medicine
Patricia LoRusso is an internationally recognized expert in drug development and early-phase clinical investigation of novel cancer therapies.
Source: YaleNews
5 Feb 2024
News
Experts Forecast 2024, Part 3: Precision Medicine for Cancer Treatment
In anticipation of the new year, we asked four experts to predict the advances we might see in 2024 in their respective fields. In part 3 of this four-part series, we share thoughts from AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, on advances in precision medicine.
Source: AACR
30 Jan 2024
News
Shasqi Appoints Dr. Pat LoRusso as Oncology Luminary to its Inaugural Scientific Advisory Board
Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team.
Source: NBC News 12
2 Aug 2023
News
Early Exposure to Medicine Inspired Committed Careers in Cancer Care
By their early 20s, two of Yale’s most prominent cancer experts had each been immersed in health care battles for many years. Few people would have been surprised if they chose careers outside of health care. Instead, Drs. Eric Winer and Patricia LoRusso chose to pursue cancer care and research as their work. Both Dr. Winer and Dr. LoRusso are now leaders of two of the country’s most prestigious organizations for cancer professionals.
7 Jun 2023